Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Current Deferred Revenue: 2019-2025

Historic Current Deferred Revenue for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to $2.8 million.

  • Biodesix's Current Deferred Revenue rose 300.00% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 300.00%. This contributed to the annual value of $700,000 for FY2024, which is 116.05% up from last year.
  • According to the latest figures from Q3 2025, Biodesix's Current Deferred Revenue is $2.8 million, which was up 353.81% from $617,000 recorded in Q2 2025.
  • In the past 5 years, Biodesix's Current Deferred Revenue ranged from a high of $2.8 million in Q3 2025 and a low of $313,000 during Q1 2024.
  • Over the past 3 years, Biodesix's median Current Deferred Revenue value was $700,000 (recorded in 2024), while the average stood at $875,818.
  • Per our database at Business Quant, Biodesix's Current Deferred Revenue plummeted by 72.37% in 2024 and then spiked by 300.00% in 2025.
  • Over the past 5 years, Biodesix's Current Deferred Revenue (Quarterly) stood at $1.9 million in 2021, then plummeted by 47.37% to $1.0 million in 2022, then plummeted by 67.60% to $324,000 in 2023, then surged by 116.05% to $700,000 in 2024, then surged by 300.00% to $2.8 million in 2025.
  • Its last three reported values are $2.8 million in Q3 2025, $617,000 for Q2 2025, and $800,000 during Q1 2025.